In kidney disease, testing a daily pill for kidney protection
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new daily pill (called HRS-7535) that may help protect kidney function in people with chronic kidney disease. It works like a natural hormone to help control blood sugar and reduce inflammation, and the researchers want to see if it can slow down kidney damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with chronic kidney disease (long-term kidney damage).
- Your kidney function (eGFR) is at least 20, and you have a certain level of protein in your urine (UACR).
- You are not on dialysis and have not had a kidney transplant, and are not planning one during the study.
- You have no personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or a related genetic condition (MEN2).
- You have not recently (in the last 3 months) had severe stomach or bowel problems, gallbladder disease, or pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests a new medicine called HS-10390 to see if it can help people with chronic kidney disease. It might slow down the disease and protect your kidneys.
This study tests a new medicine, SAL0140, at different doses to see if it can help people with chronic kidney disease. It may reduce protein in the urine, which is a sign of kidney damage.
This trial tests a new medication called survodutide to see if it can reduce protein in the urine and protect kidney function in people with chronic kidney disease. It may be an option for people who already take standard blood pressure and kidney-protecting pills.
This study tests different doses of an investigational medicine (NNC0519-0130) to see if it can reduce kidney damage in people with chronic kidney disease. It may be an option for you if you have kidney impairment and either have or don't have type 2 diabetes.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.